Daniel Brown
Last active: 4/26/2016

Radiation emission from patients treated with selective hepatic radioembolization using yttrium-90 microspheres: are contact restrictions necessary?

McCann JW, Larkin AM, Martino LJ, Eschelman DJ, Gonsalves CF, Brown DB
J Vasc Interv Radiol. 2012 23 (5): 661-7

PMID: 22440592 · DOI:10.1016/j.jvir.2012.01.070

PURPOSE - To estimate the possible radiation dose to other individuals from patients treated with yttrium-90 ((90)Y).

MATERIALS AND METHODS - Dosimetry data were analyzed after 143 consecutive administrations of (90)Y (124 resin, 19 glass) in 86 patients. External radiation exposure levels from patients were measured immediately after infusion. Total effective dose equivalent (TEDE) to maximally exposed individuals was calculated based on total body residence time and measured dose rate. These values were compared to Nuclear Regulatory Commission (NRC) regulations (maximum, 1 mSv) and other potential guidelines for caregivers, extensive caregivers, or pregnant contacts.

RESULTS - Mean administered activity for resin microspheres was 0.71 GBq ± 0.35 (range, 0.07-1.6GBq). Mean TEDE dose to the maximally exposed contact was 0.03 mSv (range, 0.0005-0.16 mSv). For glass microspheres, mean administered activity was 2.8 GBq ± 1.5 (range, 0.37-5.14 GBq). Mean TEDE dose to the maximally exposed contact was 0.06 mSv (range, 0.0023-0.23 mSv). All (90)Y treatments were within current NRC regulations for release without instructions. One, three, and one infusion were beyond potential thresholds for caregivers, extensive caregivers, or pregnant contacts, respectively. For any contact scenario, release without instruction was appropriate when administered activity was less than 3 GBq.

CONCLUSIONS - All patients treated with (90)Y hepatic radioembolization to a maximum administered activity of 5.14 GBq and maximum dose rate of 10 uSv/h were releasable without contact restrictions according to the NRC contact scenario. Patients who receive more than 3 GBq during infusion may require dose rate measurement if more restrictive contact scenarios are considered.

Copyright © 2012 SIR. Published by Elsevier Inc. All rights reserved.

MeSH Terms (22)

Caregivers Embolization, Therapeutic Female Hepatic Artery Humans Liver Neoplasms Male Microspheres Patient Discharge Philadelphia Pregnancy Pregnancy Complications Radiation Dosage Radiation Injuries Radiation Monitoring Radiopharmaceuticals Radiotherapy Dosage Risk Assessment Risk Factors Time Factors Treatment Outcome Yttrium Radioisotopes

Connections (1)

This publication is referenced by other Labnodes entities:

Links